Hierdie inligting is slegs vir opvoedkundige doeleindes. Dit is nie bedoel as mediese advies nie. Raadpleeg altyd 'n gekwalifiseerde gesondheidsorgpraktisyn.
Beskrywing, Dosering, Newe-effekte, Kontra-indikasies. Data from EMA, URPL, openFDA and other regulatory sources.
| Fluoxetine | Sertraline | |
|---|---|---|
| Aktiewe bestanddele | FLUOXETINE HYDROCHLORIDE | SERTRALINE HYDROCHLORIDE |
| ATC-kode | N06AB03 | N06AB06 |
| Vorm | CAPSULE | TABLET, FILM COATED |
| Dosering | 40 mg/1 | 50 mg/1 |
| Toedieningsweg | ORAL | ORAL |
| Vervaardiger | Preferred Pharmaceuticals Inc. | Exelan Pharmaceuticals, Inc. |
Fluoxetine (INN: FLUOXETINE HYDROCHLORIDE, ATC N06AB03) and Sertraline (INN: SERTRALINE HYDROCHLORIDE, ATC N06AB06) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Hierdie inligting is slegs vir opvoedkundige doeleindes. Dit is nie bedoel as mediese advies nie. Raadpleeg altyd 'n gekwalifiseerde gesondheidsorgpraktisyn.